Sentynl Therapeutics, a wholly owned subsidiary of Zydus Lifesciences Ltd. (Zydus), is a commercial stage biopharmaceutical company focused on bringing innovative therapies to patients living with rare diseases. With an emphasis on commercialization, Sentynl looks to acquire, develop and commercialize well-differentiated products across a broad spectrum of therapeutic areas to address a variety of genetic orphan and neurological disorders.
The Director of Clinical Operations will provide strategic and operational leadership in the planning, execution, and oversight of clinical study programs across the full development lifecycle (Phase 2/3 through Phase 4). This role is accountable for the successful delivery of studies within the Clinical Development Plan whether conducted in-house or outsourced to third-party vendors. Working cross-functionally with internal stakeholders and external partners, the Director, Clinical Operations will manage timelines, budgets, and resources while ensuring regulatory compliance and operational excellence.
The work environment characteristics described here are representative of those an individual would experience while performing the essential functions of this job.
Growth
Accountability
Transparency
Ethics
Sentynl Therapeutics, Inc. offers a competitive salary program and an attractive benefits package that includes: